Thursday
SESSION XII: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS: THE STATE-OF-THE-ART, NEW ADJUNCTS AND DEBATES (5 AND 6-MINUTE FAST PACED TALKS)
SESSION XII SCHEDULE
10:24 AM - 10:29 AM Debate: Long-Term (5-Year) Results Of BASIL Trial Show “Open Surgery First” To Be Superior To “Endovascular Treatment First” For Critical Limb Ischemia
  Presenters(s): Andrew W. Bradbury, M.D., FRCSEd  
10:30 AM - 10:35 AM Debate:“Endovascular Treatment First” Is Better For Critical Ischemia Based On High Perioperative Morbidity For Contemporary Infrainguinal Open Surgery: Is The U.S. Different From The UK?
  Presenters(s): Glenn M. LaMuraglia, M.D.  
10:36 AM - 10:41 AM Debate:Endovascular Treatment First Decreases The Need For Bypasses Without Increasing Amputation Rate
  Presenters(s): Samuel E. Wilson, M.D.  
10:42 AM - 10:48 AM What Is The Level I Evidence That Nitinol Stents Are Better Than POBA For Femoropopliteal And Infrapopliteal Disease: Are 2-Year Results Available?
  Presenters(s): Thomas Rand, M.D. / Johannes Lammer, M.D.  
10:49 AM - 10:55 AM Is There Any Role For Atherectomy, Lasers, Cryoplasty, Bypass, etc. For Infrainguinal Occlusive Disease With Critical Ischemia: Subintimal Angioplasty Is Just As Good: Are There Any New Better Wires Or Catheters?
  Presenters(s): Amman Bolia, M.D.  
10:56 AM - 11:01 AM Debate:The Fox Hollow Rotational Atherectomy Device (Silverhawk) Is Effective After 2 Or More Years
  Presenters(s): James F. McKinsey, M.D.  
11:02 AM - 11:07 AM Debate:The Fox Hollow Rotational Atherectomy Device (Silverhawk) Is Not Effective After 2 Or More Years
  Presenters(s): Julio A. Rodriguez-Lopez, M.D.  
11:08 AM - 11:15 AM Panel Discussion
Moderator(s): Frank J. Veith, M.D. / Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E.  
11:15 AM - 11:20 AM Update And New Findings From The RESILIENT Trial Comparing The (Bard) Lifestent With POBA: Is The Improvement With Stenting Durable Beyond 1 Year?
  Presenters(s): Barry T. Katzen, M.D.  
11:21 AM - 11:26 AM Update On Results With The Drug Coated Nitinol PTX Stent (Paclitaxol Without Polymer) From Cook: Results To 1 Year And Beyond
  Presenters(s): Michael D. Dake, M.D.  
11:27 AM - 11:32 AM 12-Month Results With The Lifestent (Bard) For Popliteal Lesions
  Presenters(s): Koen Deloose, M.D. / Marc Bosiers, M.D.  
11:33 AM - 11:38 AM Challenge Of Treating Calcified Lesions Endovascularly: Tips, Tricks, Long-Term Results And Value Of The IDEV Stent
  Presenters(s): Dierk Scheinert, M.D.  
11:39 AM - 11:45 AM Paclitaxol Coated Balloons Improve Results Of PTA For SFA Lesions: Results Of The THUNDER Trial At 12 Months And Will Cypher Drug Eluting Stents Prevent Restenosis That Occurs With Bare Metal Stents?
  Presenters(s): Gunnar Tepe, M.D.  
11:46 AM - 11:51 AM The Value Of Drug-Eluting Stents For Infrapopliteal Artery Lesions: A New Horizon
  Presenters(s): Konstantinos Katsanos, M.D. / Dimitris Siablis, M.D., Ph.D.  
11:52 AM - 11:57 AM Retrograde Pedal Approach For Difficult Tibial And Popliteal Lesions: Technique, Indications And Results: The SAFARI Approach – A New Endovascular Advance
  Presenters(s): Dierk Scheinert, M.D. / Marcus Thieme, M.D. / Andrej Schmidt, M.D.  
11:58 AM - 12:10 PM Panel Discussion
12:10 PM - 1:00 PM Lunch Break
END OF SESSION XII
previous next